Concepts (49)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Oncolytic Virotherapy | 8 | 2023 | 280 | 2.680 |
Why?
|
| Oncolytic Viruses | 6 | 2023 | 204 | 2.060 |
Why?
|
| Adenoviridae | 6 | 2023 | 1459 | 1.580 |
Why?
|
| Immunotherapy, Adoptive | 4 | 2021 | 1763 | 0.880 |
Why?
|
| Adoptive Transfer | 1 | 2018 | 446 | 0.550 |
Why?
|
| Interleukin-12 | 3 | 2021 | 253 | 0.480 |
Why?
|
| Genetic Therapy | 2 | 2020 | 1616 | 0.440 |
Why?
|
| T-Lymphocytes | 3 | 2021 | 3869 | 0.400 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2021 | 1724 | 0.360 |
Why?
|
| Neoplasms | 6 | 2023 | 15193 | 0.310 |
Why?
|
| B7-H1 Antigen | 3 | 2021 | 1022 | 0.300 |
Why?
|
| Combined Modality Therapy | 2 | 2020 | 8865 | 0.290 |
Why?
|
| Xenograft Model Antitumor Assays | 4 | 2021 | 3821 | 0.230 |
Why?
|
| Pancreatic Neoplasms | 1 | 2021 | 5061 | 0.230 |
Why?
|
| Tumor Burden | 2 | 2021 | 1987 | 0.230 |
Why?
|
| Receptors, Antigen, T-Cell | 3 | 2020 | 1146 | 0.220 |
Why?
|
| Head and Neck Neoplasms | 1 | 2017 | 3976 | 0.210 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2017 | 1555 | 0.200 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2017 | 5437 | 0.200 |
Why?
|
| Receptor, ErbB-2 | 3 | 2021 | 2518 | 0.200 |
Why?
|
| Single-Chain Antibodies | 1 | 2021 | 62 | 0.190 |
Why?
|
| Coculture Techniques | 1 | 2021 | 626 | 0.170 |
Why?
|
| Lymphocyte Transfusion | 1 | 2017 | 175 | 0.140 |
Why?
|
| Antibodies, Neoplasm | 1 | 2017 | 259 | 0.140 |
Why?
|
| Viral Tropism | 1 | 2016 | 40 | 0.140 |
Why?
|
| Antibodies, Bispecific | 1 | 2020 | 246 | 0.140 |
Why?
|
| Transduction, Genetic | 1 | 2016 | 475 | 0.130 |
Why?
|
| Tumor Microenvironment | 2 | 2023 | 2864 | 0.120 |
Why?
|
| Antibodies, Neutralizing | 1 | 2017 | 541 | 0.110 |
Why?
|
| Cell Line, Tumor | 3 | 2023 | 14551 | 0.100 |
Why?
|
| Neoplasm Metastasis | 1 | 2021 | 5112 | 0.090 |
Why?
|
| Gene Expression | 1 | 2017 | 3570 | 0.080 |
Why?
|
| Animals | 5 | 2023 | 59536 | 0.080 |
Why?
|
| Survival Analysis | 1 | 2017 | 9180 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 1 | 2017 | 4367 | 0.060 |
Why?
|
| Mice | 3 | 2023 | 34495 | 0.060 |
Why?
|
| Humans | 6 | 2021 | 261506 | 0.050 |
Why?
|
| Female | 4 | 2021 | 141928 | 0.050 |
Why?
|
| Clinical Studies as Topic | 1 | 2020 | 19 | 0.050 |
Why?
|
| Hyaluronan Receptors | 1 | 2020 | 249 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2020 | 905 | 0.040 |
Why?
|
| A549 Cells | 1 | 2017 | 124 | 0.040 |
Why?
|
| Hep G2 Cells | 1 | 2017 | 155 | 0.040 |
Why?
|
| Male | 3 | 2021 | 123000 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2020 | 1869 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 2020 | 1694 | 0.030 |
Why?
|
| Cytokines | 1 | 2023 | 2809 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2017 | 4307 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2020 | 32848 | 0.020 |
Why?
|